世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000038974

非増殖糖尿病性網膜症の世界市場レポート(2024年)

The Business Research Company

Non-Proliferative Diabetic Retinopathy Global Market Report 2024

発刊日 2024/07/15

言語英語

体裁PDF/175ページ

ライセンス/価格175ページ

0000038974

Single
Site
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※受注後、レポートは最新版へ更新されますので、納品までに3〜5営業日かかります。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

本レポートは、非増殖糖尿病性網膜症の世界市場に関して、戦略家、マーケティング担当者、上級管理職が市場を評価するために必要な重要情報を提供します。

本レポートは、力強い成長を遂げている非増殖糖尿病性網膜症市場に焦点を当て、今後10年およびそれ以降の市場を形成するトレンドについてのガイドを提供します。

調査範囲

  • 調査市場
    ➣ 治療タイプ別
      ◇ 抗血管内皮増殖因子(VEGF)療法
      ◇ 眼内ステロイド注射
      ◇ レーザー手術
      ◇ 硝子体切除術
    ➣ 疾患重症度別
      ◇ 軽度非増殖糖尿病性網膜症
      ◇ 中程度非増殖糖尿病性網膜症
      ◇ 重度非増殖糖尿病性網膜症
    ➣ エンドユーザー別
      ◇ 病院
      ◇ 専門クリニック
      ◇ 外来手術センター
      ◇ その他のエンドユーザー
  • 調査企業
    ➣ Pfizer Inc
    ➣ Johnson & Johnson
    ➣ F. Hoffmann-La Roche AG
    ➣ AbbVie Inc.
    ➣ Bayer AG
  • 調査国
    オーストラリア、ブラジル、中国、フランス、ドイツ、インド、インドネシア、日本、ロシア、韓国、イギリス、アメリカ、カナダ、イタリア、スペイン
  • 調査地域
    ➣ アジア太平洋地域
    ➣ 西ヨーロッパ
    ➣ 東ヨーロッパ
    ➣ 北アメリカ
    ➣ 南アメリカ
    ➣ 中東
    ➣ アフリカ
  • 調査期間
    ➣ 5年間の実績データおよび10年間の予測
  • データ
    ➣ 市場規模と成長率の関連市場に対する比率
    ➣ GDP比率
    ➣ 一人当たりの支出
  • データセグメント
    ➣ 国別・地域別の実績および予測データ
    ➣ 競合企業の市場シェア
    ➣ 市場セグメント
  • 情報源および参照
    ➣ 本レポートのデータおよび分析は、注釈で出典を明らかにしています。
  • 提供形態
    ➣ PDF、Word、Excelデータダッシュボード

レポート詳細

目次

Table of Contents

1. Executive Summary

2. Non-Proliferative Diabetic Retinopathy Market Characteristics

3. Non-Proliferative Diabetic Retinopathy Market Trends And Strategies

4. Non-Proliferative Diabetic Retinopathy Market - Macro Economic Scenario
4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Non-Proliferative Diabetic Retinopathy Market Size and Growth
5.1. Global Non-Proliferative Diabetic Retinopathy Market Drivers and Restraints
5.1.1. Drivers Of The Market
5.1.2. Restraints Of The Market
5.2. Global Non-Proliferative Diabetic Retinopathy Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Non-Proliferative Diabetic Retinopathy Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Non-Proliferative Diabetic Retinopathy Market Segmentation
6.1. Global Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Anti-Vascular Endothelial Growth Factor (VEGF) Therapy
Intraocular Steroid Injection
Laser Surgery
Vitrectomy
6.2. Global Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Mild Non-Proliferative Diabetic Retinopathy
Moderate Non-Proliferative Diabetic Retinopathy
Severe Non-Proliferative Diabetic Retinopathy
6.3. Global Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Other End-Users

7. Non-Proliferative Diabetic Retinopathy Market Regional And Country Analysis
7.1. Global Non-Proliferative Diabetic Retinopathy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Non-Proliferative Diabetic Retinopathy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Non-Proliferative Diabetic Retinopathy Market
8.1. Asia-Pacific Non-Proliferative Diabetic Retinopathy Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Non-Proliferative Diabetic Retinopathy Market
9.1. China Non-Proliferative Diabetic Retinopathy Market Overview
9.2. China Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Non-Proliferative Diabetic Retinopathy Market
10.1. India Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Non-Proliferative Diabetic Retinopathy Market
11.1. Japan Non-Proliferative Diabetic Retinopathy Market Overview
11.2. Japan Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Non-Proliferative Diabetic Retinopathy Market
12.1. Australia Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Non-Proliferative Diabetic Retinopathy Market
13.1. Indonesia Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Non-Proliferative Diabetic Retinopathy Market
14.1. South Korea Non-Proliferative Diabetic Retinopathy Market Overview
14.2. South Korea Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Non-Proliferative Diabetic Retinopathy Market
15.1. Western Europe Non-Proliferative Diabetic Retinopathy Market Overview
15.2. Western Europe Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Non-Proliferative Diabetic Retinopathy Market
16.1. UK Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Non-Proliferative Diabetic Retinopathy Market
17.1. Germany Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Non-Proliferative Diabetic Retinopathy Market
18.1. France Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Non-Proliferative Diabetic Retinopathy Market
19.1. Italy Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Non-Proliferative Diabetic Retinopathy Market
20.1. Spain Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Non-Proliferative Diabetic Retinopathy Market
21.1. Eastern Europe Non-Proliferative Diabetic Retinopathy Market Overview
21.2. Eastern Europe Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Non-Proliferative Diabetic Retinopathy Market
22.1. Russia Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Non-Proliferative Diabetic Retinopathy Market
23.1. North America Non-Proliferative Diabetic Retinopathy Market Overview
23.2. North America Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Non-Proliferative Diabetic Retinopathy Market
24.1. USA Non-Proliferative Diabetic Retinopathy Market Overview
24.2. USA Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Non-Proliferative Diabetic Retinopathy Market
25.1. Canada Non-Proliferative Diabetic Retinopathy Market Overview
25.2. Canada Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Non-Proliferative Diabetic Retinopathy Market
26.1. South America Non-Proliferative Diabetic Retinopathy Market Overview
26.2. South America Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Non-Proliferative Diabetic Retinopathy Market
27.1. Brazil Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Non-Proliferative Diabetic Retinopathy Market
28.1. Middle East Non-Proliferative Diabetic Retinopathy Market Overview
28.2. Middle East Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Non-Proliferative Diabetic Retinopathy Market
29.1. Africa Non-Proliferative Diabetic Retinopathy Market Overview
29.2. Africa Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Non-Proliferative Diabetic Retinopathy Market Competitive Landscape And Company Profiles
30.1. Non-Proliferative Diabetic Retinopathy Market Competitive Landscape
30.2. Non-Proliferative Diabetic Retinopathy Market Company Profiles
30.2.1. Pfizer Inc.
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Johnson & Johnson
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. F. Hoffmann-La Roche AG
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. AbbVie Inc.
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Bayer AG
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance

31. Non-Proliferative Diabetic Retinopathy Market Other Major And Innovative Companies
31.1. Abbott Laboratories
31.2. Novartis AG
31.3. Eli Lilly and Company
31.4. Novo Nordisk A/S
31.5. Regeneron Pharmaceuticals Inc.
31.6. Bausch Health Companies Inc.
31.7. Boehringer Ingelheim International GmbH
31.8. Genentech Inc.
31.9. Carl Zeiss Meditec AG
31.10. ZEISS Group
31.11. Santen Pharmaceutical Co. Ltd.
31.12. Santen Inc.
31.13. Topcon Corporation
31.14. Lumenis Ltd.
31.15. Alimera Science

32. Global Non-Proliferative Diabetic Retinopathy Market Competitive Benchmarking

33. Global Non-Proliferative Diabetic Retinopathy Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Non-Proliferative Diabetic Retinopathy Market

35. Non-Proliferative Diabetic Retinopathy Market Future Outlook and Potential Analysis
35.1 Non-Proliferative Diabetic Retinopathy Market In 2028 - Countries Offering Most New Opportunities
35.2 Non-Proliferative Diabetic Retinopathy Market In 2028 - Segments Offering Most New Opportunities
35.3 Non-Proliferative Diabetic Retinopathy Market In 2028 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies

36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

List of Tables
Table 1: Global Historic Market Growth, 2018-2023, $ Billion
Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
Table 3: Global Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 4: Global Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 5: Global Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 6: Global Non-Proliferative Diabetic Retinopathy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 7: Global Non-Proliferative Diabetic Retinopathy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 8: Asia-Pacific, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 9: Asia-Pacific, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 10: Asia-Pacific, Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 11: China, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 12: China, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 13: China, Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 14: India, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 15: India, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 16: India, Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 17: Japan, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 18: Japan, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 19: Japan, Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 20: Australia, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 21: Australia, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 22: Australia, Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 23: Indonesia, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 24: Indonesia, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 25: Indonesia, Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 26: South Korea, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 27: South Korea, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 28: South Korea, Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 29: Western Europe, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 30: Western Europe, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 31: Western Europe, Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 32: UK, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 33: UK, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 34: UK, Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 35: Germany, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 36: Germany, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 37: Germany, Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 38: France, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 39: France, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 40: France, Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 41: Italy, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 42: Italy, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 43: Italy, Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 44: Spain, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 45: Spain, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 46: Spain, Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 47: Eastern Europe, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 48: Eastern Europe, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 49: Eastern Europe, Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 50: Russia, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 51: Russia, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 52: Russia, Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 53: North America, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 54: North America, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 55: North America, Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 56: USA, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 57: USA, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 58: USA, Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 59: Canada, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 60: Canada, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 61: Canada, Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 62: South America, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 63: South America, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 64: South America, Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 65: Brazil, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 66: Brazil, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 67: Brazil, Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 68: Middle East, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 69: Middle East, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 70: Middle East, Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 71: Africa, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 72: Africa, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 73: Africa, Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 74: Pfizer Inc. Financial Performance
Table 75: Johnson & Johnson Financial Performance
Table 76: F. Hoffmann-La Roche AG Financial Performance
Table 77: AbbVie Inc. Financial Performance
Table 78: Bayer AG Financial Performance

List of Figures
Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
Figure 3: Global Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 4: Global Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 5: Global Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 6: Global Non-Proliferative Diabetic Retinopathy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 7: Global Non-Proliferative Diabetic Retinopathy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 8: Asia-Pacific, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 9: Asia-Pacific, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 10: Asia-Pacific, Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 11: China, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 12: China, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 13: China, Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 14: India, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 15: India, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 16: India, Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 17: Japan, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 18: Japan, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 19: Japan, Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 20: Australia, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 21: Australia, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 22: Australia, Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 23: Indonesia, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 24: Indonesia, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 25: Indonesia, Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 26: South Korea, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 27: South Korea, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 28: South Korea, Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 29: Western Europe, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 30: Western Europe, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 31: Western Europe, Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 32: UK, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 33: UK, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 34: UK, Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 35: Germany, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 36: Germany, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 37: Germany, Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 38: France, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 39: France, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 40: France, Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 41: Italy, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 42: Italy, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 43: Italy, Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 44: Spain, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 45: Spain, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 46: Spain, Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 47: Eastern Europe, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 48: Eastern Europe, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 49: Eastern Europe, Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 50: Russia, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 51: Russia, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 52: Russia, Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 53: North America, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 54: North America, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 55: North America, Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 56: USA, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 57: USA, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 58: USA, Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 59: Canada, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 60: Canada, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 61: Canada, Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 62: South America, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 63: South America, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 64: South America, Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 65: Brazil, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 66: Brazil, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 67: Brazil, Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 68: Middle East, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 69: Middle East, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 70: Middle East, Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 71: Africa, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 72: Africa, Non-Proliferative Diabetic Retinopathy Market, Segmentation By Disease Severity Level, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 73: Africa, Non-Proliferative Diabetic Retinopathy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 74: Pfizer Inc. Financial Performance
Figure 75: Johnson & Johnson Financial Performance
Figure 76: F. Hoffmann-La Roche AG Financial Performance
Figure 77: AbbVie Inc. Financial Performance
Figure 78: Bayer AG Financial Performance

この商品のレポートナンバー

0000038974

TOP